A role for dystroglycan in the pathophysiology of acute leukemic cells.

Article English OPEN
Alonso-Rangel, L.; Benítez-Guerrero, T.; Martínez-Vieyra, I.; Cisneros, B.; Martínez-Tovar, A.; Winder, S.J.; Cerecedo, D.;
  • Publisher: Elsevier
  • Subject:
    mesheuropmc: hemic and lymphatic diseases

AIMS: Previous reports have demonstrated that alterations or reduced expression of Dystroglycan (Dg) complex (αDg and βDg subunits) are related to progression and severity of neoplastic solid tissues. Therefore we determined the expression pattern and subcellular distri... View more
  • References (40)
    40 references, page 1 of 4

    1. Ibraghimov-Beskrovnaya, O., J.M. Ervasti, C.J. Leveille, C.A. Slaughter, S.W. Sernett, and K.P. Campbell. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature, 1992. 355(6362): p. 696-702.

    2. Ervasti, J.M. and K.P. Campbell. A role for the dystrophinglycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol, 1993. 122(4): p. 809-823.

    3. Martin, P.T. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Glycobiology, 2003. 13(8): p. 55R-66R.

    4. Winder, S.J. The membrane-cytoskeleton interface: the role of dystrophin and utrophin. J Muscle Res Cell Motil, 1997. 18(6): p. 617-629.

    5. Kanagawa, M., D.E. Michele, J.S. Satz, R. Barresi, H. Kusano, T. Sasaki, R. Timpl, M.D. Henry, and K.P. Campbell. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. FEBS Lett, 2005. 579(21): p. 4792-4796.

    6. Streuli, C.H., C. Schmidhauser, N. Bailey, P. Yurchenco, A.P. Skubitz, C. Roskelley, and M.J. Bissell. Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol, 1995. 129(3): p. 591- 603.

    7. Patarroyo, M., K. Tryggvason, and I. Virtanen. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol, 2002. 12(3): p. 197-207.

    8. Moore, C.J. and S.J. Winder. The inside and out of dystroglycan posttranslational modification. Neuromuscul Disord, 2012. 22(11): p. 959-965.

    9. Spence, H.J., A.S. Dhillon, M. James, and S.J. Winder. Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep, 2004. 5(5): p. 484- 489.

    10. Taniguchi-Ikeda, M., I. Morioka, K. Iijima, and T. Toda. Mechanistic aspects of the formation of alpha-dystroglycan and therapeutic research for the treatment of alpha-dystroglycanopathy: a review. Mol Aspects Med, 2016. 51: p. 115-124.

  • Related Research Results (1)
  • Similar Research Results (3)
  • Metrics
Share - Bookmark